Treatment with Andembry (garadacimab) may help prevent recurrent hereditary angioedema (HAE) attacks for years, with longer attack-free periods linked to better quality of life, according to a study based on statistical predictions. The study, “Garadacimab in Hereditary Angioedema: Modeling Suggests Sustained Improvements in Attack-Free Probability and Quality…
Discussion
People with hereditary angioedema (HAE) showed better disease control and quality of life during treatment with Andembry (garadacimab-gxii), a small real-world study in Germany found. Many were also able to go longer between injections under medical supervision. After about six months, nearly all patients who were assessed had…
Discussion
A single oral dose of the experimental treatment deucrictibant rapidly brought hereditary angioedema (HAE) attacks under control, significantly shortening the time to symptom relief, stopping attacks from worsening sooner, and speeding complete symptom resolution compared with a placebo. That’s according to results from the now-completed Phase 3 RAPIDe-3 trial…
Discussion
The U.S. Food and Drug Administration (FDA) has approved an oral pellet version of Orladeyo (berotralstat) for teens and adults with hereditary angioedema (HAE), expanding access to a formulation previously available only for young children. Developed by Biocryst Pharmaceuticals, the once-daily preventive treatment was previously approved as…
Angioedema is the formal medical term for swelling under the skin. It usually occurs as part of an allergic reaction, but has forms that are not due to allergies.
Acute angioedema often occurs as part of an allergic reaction to various allergens or triggers. These can include certain foods, insect bites or stings, medications, and natural rubber products like latex.
Angioedema and hives often occur at the same time. However, angioedema causes large, thick welts which may not be itchy, whereas hives are smaller and usually itchy.
Get regular updates to your inbox.
